Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.

Benzer Materyaller

• Chemotherapy of Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide (DTIC) and Nitrosourea Derivatives (BCNU, CCNU)
  Yazar:: Hill, George J., ve diğerleri
  Baskı/Yayın Bilgisi: (1974)
• Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma
  Yazar:: Yang, Xi, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
  Yazar:: Larsson, P. G., ve diğerleri
  Baskı/Yayın Bilgisi: (1979)
• 1-(3-Chloro­phen­yl)-2-methyl-4-nitro-1H-imidazole-5-carboxamide
  Yazar:: Korzański, Artur, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Post-irradiation sensitization with the ADP-ribosyltransferase inhibitor 3-acetamidobenzamide.
  Yazar:: Lunec, J., ve diğerleri
  Baskı/Yayın Bilgisi: (1984)